USD 17.35
(-11.66%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 394 Million | 546 Million | 599 Million | 271 Million | 300 Million |
Net Income | -27 Million | -82 Million | -75 Million | -196 Million | -328 Million |
Depreciation & Amortization | 513 Million | 567 Million | 526 Million | 463 Million | 338 Million |
Deferred income taxes | -14 Million | -9 Million | -29 Million | -53 Million | -32 Million |
Stock-based compensation | 252 Million | 174 Million | 97 Million | 85 Million | 76 Million |
Change in working capital | -352 Million | -138 Million | 80 Million | -24 Million | -12 Million |
Other non-cash items | 22 Million | 34 Million | 1.1 Billion | -4 Million | 258 Million |
Investing Cash Flow | -98 Million | 1.18 Billion | -157 Million | -965 Million | -225 Million |
Investments in PPE | -98 Million | -111 Million | -143 Million | -91 Million | -44 Million |
Acquisitions | - | - | - | -745 Million | - |
Investment purchases | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - |
Other Investing Activities | - | 1.29 Billion | -14 Million | -129 Million | -181 Million |
Financing Cash Flow | -100 Million | -1.31 Billion | 91 Million | 732 Million | -59 Million |
Debt repayment | - | - | - | - | - |
Dividends payments | - | -1.25 Billion | - | - | - |
Common Stock Repurchased | - | - | - | -15 Million | -1 Million |
Common Stock Issuance | - | 1.03 Billion | - | - | - |
Other Financing Activities | -100 Million | -2.01 Billion | 91 Million | 747 Million | -58 Million |
Accounts receivables | -88 Million | -114 Million | -62 Million | 7 Million | -23 Million |
Accounts payables | 10 Million | 58 Million | 75 Million | -14 Million | -4 Million |
Inventory | -278 Million | -16 Million | 31 Million | -25 Million | -26 Million |
Other working capital | 4 Million | -66 Million | 36 Million | 8 Million | 41 Million |
Cash at beginning of period | 1.02 Billion | 625 Million | 93 Million | 55 Million | 39 Million |
Cash at end of period | 1.21 Billion | 1.03 Billion | 625 Million | 93 Million | 55 Million |
Capital Expenditure | -98 Million | -111 Million | -143 Million | -91 Million | -44 Million |
Effect of forex changes on cash | -5 Million | -6 Million | -1 Million | - | - |
Net cash flow / Change in cash | 188 Million | 410 Million | 532 Million | 38 Million | 16 Million |
Free Cash Flow | 296 Million | 435 Million | 456 Million | 180 Million | 256 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -2.71 Billion | -86 Million | -218 Million | 63 Million | -27 Million | 17 Million |
Depreciation & Amortization | 127 Million | 127 Million | 125 Million | 127 Million | 513 Million | 120 Million |
Deferred income taxes | -87.09 Million | -4.9 Million | -6 Million | -918.58 Thousand | -14 Million | -3 Million |
Stock-based compensation | 79 Million | 62 Million | 62 Million | 62 Million | 252 Million | 63 Million |
Change in working capital | -3.96 Million | -71.03 Million | 75 Million | -134.33 Million | -352 Million | -112 Million |
Other non-cash items | 2.72 Billion | 420.26 Million | 225 Million | -12.58 Million | 22 Million | 3 Million |
Investing Cash Flow | -34.52 Million | -41.47 Million | -22 Million | -21.92 Million | -98 Million | -17 Million |
Investments in PPE | -22.37 Million | -23.62 Million | -22 Million | -21.92 Million | -98 Million | -17 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | -14.14 Million | -17.85 Million | - | - | - | - |
Sales/Maturities of investments | 2 Million | - | - | - | - | - |
Other Investing Activities | - | -18 Million | - | - | - | - |
Financing Cash Flow | -5.09 Million | -6.9 Million | -4 Million | -68.4 Million | -100 Million | -17 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -5.09 Million | -6.9 Million | -4 Million | -68.4 Million | -100 Million | -17 Million |
Accounts receivables | -18.91 Million | -84.08 Million | 216 Million | -90.72 Million | -88 Million | -23 Million |
Accounts payables | -3.42 Million | 10.42 Million | -62 Million | -10.68 Million | 10 Million | 18 Million |
Inventory | 27.22 Million | -28.22 Million | -65 Million | -34.84 Million | -278 Million | -91 Million |
Other working capital | -16.86 Million | 30.86 Million | -14 Million | 1.92 Million | 4 Million | -16 Million |
Cash at beginning of period | 1.2 Billion | 1.23 Billion | 1.21 Billion | 1.19 Billion | 1.02 Billion | 1.15 Billion |
Cash at end of period | 1.3 Billion | 1.2 Billion | 1.22 Billion | 1.21 Billion | 1.21 Billion | 1.2 Billion |
Capital Expenditure | -22.37 Million | -23.62 Million | -22 Million | -21.92 Million | -98 Million | -17 Million |
Effect of forex changes on cash | 3 Million | -3 Million | -2 Million | 4 Million | -5 Million | -4 Million |
Net cash flow / Change in cash | 103 Million | -35 Million | 11 Million | 19 Million | 188 Million | 50 Million |
Free Cash Flow | 104.19 Million | 5.8 Million | 18 Million | 82.23 Million | 296 Million | 71 Million |
KEN
ARZTF
CHMI
7729
CNVVY
FULO